Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(42)
•••
Comment by MineDiggeron Oct 07, 2014 12:53pm
140 Views
Post# 23006414

RE:RE:news oct 7

RE:RE:news oct 7crazy says "Why is this NR not on the SAFC investor press release site. Lol."

Well when I look at the page you link and count the number of NRs by SAFC listing collaberations with Clients I find NONE (goes back to March 2013!).

So either SAFC don't do SOP and GMP for anyone (except TLT?), or they just don't do NRs for this stuff and leave it to the client to make control the news (which may be confidential etc).

If you look at their NRs they are in fact all about THEIR news, not the Clients.

So Craze, you missed that obvious fact, or deliberately miss-stated the facts to suit your view. Either way, somewhat reduces your credibility (higher crazability I guess, one up for you!).

But please keep posting (slightly less would be best, you'll get fewer Ignores perhaps), as I need someone to play the Devil's Advocate and keep us on our toes.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities